AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $884,428 | +68.2% | 209,580 | +23.5% | 0.00% | +100.0% |
| Q2 2023 | $525,884 | +103.6% | 169,640 | -8.7% | 0.00% | +100.0% |
| Q1 2023 | $258,256 | -32.7% | 185,796 | -3.7% | 0.00% | -50.0% |
| Q4 2022 | $383,762 | -6.4% | 192,845 | -5.0% | 0.00% | 0.0% |
| Q3 2022 | $410,000 | -36.9% | 202,995 | -0.7% | 0.00% | -33.3% |
| Q2 2022 | $650,000 | -11.3% | 204,335 | +16.3% | 0.00% | 0.0% |
| Q1 2022 | $733,000 | -13.9% | 175,731 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $851,000 | -11.9% | 177,631 | -1.8% | 0.00% | -25.0% |
| Q3 2021 | $966,000 | +8.2% | 180,910 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $893,000 | +126.6% | 174,420 | +197.9% | 0.00% | +100.0% |
| Q1 2021 | $394,000 | +258.2% | 58,550 | +143.6% | 0.00% | – |
| Q4 2020 | $110,000 | +18.3% | 24,035 | 0.0% | 0.00% | – |
| Q3 2020 | $93,000 | -18.4% | 24,035 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $114,000 | +3.6% | 24,035 | -23.9% | 0.00% | 0.0% |
| Q1 2020 | $110,000 | – | 31,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |